MISCAN-Fadia (Erasmus)

MIcrosimulation SCreening Analysis (MISCAN) Fatal Diameter model

Basic Model Attributes
Cancer siteBreast
Host institution Erasmus University Medical Center
Purpose In the MISCAN-Fadia model knowledge on natural history, screening and adjuvant treatment and breast cancer risk derived from randomised controlled trials and observational studies are integrated. In this way, MISCAN-Fadia is helpful in analyzing and explaining results of cancer screening trials, predicting the (cost-)effectiveness of different screening policies and predicting the effect of interventions on future national trends.
Contact Nicolien van Ravesteyn (n.vanravesteyn@erasmusmc.nl)